Prothena Corp Public Ltd Co (PRTA) stock
PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)
Close on Nov 17, 2026Market cap $424.04MP/E –Yield –
Prothena Corp Public pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Prothena Corp Public's pe ratio was 23.9× on Jul 29, 2022.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2022 | Jul 29, 2022 | 23.9× | −24.1 |
| 2021 | Dec 31, 2021 | 48.0× | – |
See a number that looks wrong?